180
Participants
Start Date
March 31, 2006
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Alpha1-proteinase inhibitor
60 mg/kg body weight/week intravenous
Placebo
Lyophilized preparation: 60 mg/kg body weight/week intravenous
Study Site, Dublin
Study Site, Darlinghurst
Study Site, New Lambton
Study Site, Hellerup
Study Site, Fitzroy
Study Site, Brisbane
Study Site, Adelaide
Study Site, Nedlands
Study Site, Aarhus
Study Site, Berlin
Study Site, Prague
Study Site, Hershey
Study Site, Malmo
Study Site, Miami
Study Site, Essen
Study Site, Tartu
Study Site, Heidelberg
Study Site, Tyler
Study Site, Denver
Study Site, Oulu
Study Site, Nuremberg
Study Site, Vancouver
Study Site, Halifax
Study Site, Toronto
Study Site, Krakow
Study Site, Warsaw
Study Site, Bucharest
Study Site, Barnaul
Lead Sponsor
CSL Behring
INDUSTRY